Davis Polk advised the sole book-running manager in connection with the $172.5 million initial public offering of 17,250,000 units of Population Health Investment Co., Inc., which includes 2,250,000 units from the full exercise of the underwriter’s over-allotment option to purchase additional units. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant to purchase one Class A ordinary share of Population Health Investment Co., Inc. The units were listed on the Nasdaq Capital Market under the symbol “PHICU.”

Population Health Investment Co., Inc. is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the company may pursue an initial business combination in any industry, sector, or geographic region, it intends to focus on companies or divisions of companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. 

The Davis Polk corporate team included partners Deanna L. Kirkpatrick and Roshni Banker Cariello and associates Gil Savir and Lia-Michelle Keane. The tax team included partner Michael Farber and associate Eitan Ulmer. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post